Skip to main content

Table 1 Patient characteristics and causes of AKI

From: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration

 

Prismocitrate 10/2

Prismocitrate 18

P value

Number of patients (n)

28

31

 

Age (years) (median [range])

73 (65–82)

68 (55–82)

0.298

Male gender (n, %)

17/28 (61 %)

21/31 (68 %)

0.598

Underlying disease/condition & cause of AKI (n, %)

 Sepsis

9/28 (32 %)

9/31 (29 %)

0.98

 Post cardiac surgery

5/28 (18 %)

10/31(32 %)

0.33

 Post general surgery

7/28 (25 %)

4/31(13 %)

0.39

 Other

7/25 (25 %)

8/31(26 %)

0.90

APACHE II score (median [range])

32 (23–41)

27 (20–34)

0.109

Mechanical ventilation (days) (median [range])

11 (1–24)

14.6 (2–26)

0.167

Vasopressor requirement (n, %)

86 %

77 %

0.451

  1. Abbreviations: APACHE II acute physiology and chronic health evaluation score II, LOS length of stay, AKI acute kidney injury